1Hollingsworth R, Sillekens P, Van P, et al. Serum HCV RNA levels assessed by quantitive NASBA: stability of viral load over time, and lack of correlation with liver disease. J Hepatol, 1996;25:301-306
2Lunel F, Mariotti M, Cresta P, et al. Comparative study of conventional and novel strateries for the detection of hepatitis C virus RNA in serum:amplicor, branched-DNA, NASBA and in-house PCR. J Virol Methods, 1995;54:159-171
3Lunel F, Cresta P, Vitour D, et al. Comparative evaluation of Hepatitis C Virus RNA Quantitation by Branched DNA, NASBA,and Monitor Assays. Hepatol, 1999;29:528-535
4Compton J. Nucleaic acid sequence-based amplication. Nature, 1991;350(6313): 91-92
5Ppeignoux M, Marcellin P, Pouteau M, et al . Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genetype are main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatol, 1995;22: 1050-1056
6Kievits T, Van G, Van S, et al. NASBA isothermal enzymatic in vitro amplication optimized for the diagnosis of HIV-1 infection. J Virol Methods, 1991;35:273-286
7Mahony J, Song X, Chong S, et al. Evaluation of the nuclisens basic kit for detection of chlamydia trachomatis and neisseria gonorrhoeae in genital tract specimens using nucleic acid sequence-based amplication of 16S r RNA. J Clin Microbial, 2001;39(4): 1429-1435
8Michel P, Maaike W, Van D, et al. Single rapid real-time monitored isothermal RNA amplication assay for quanitification of human immunodeficiency virus type I isolates from groups M, N, and O. J Clin Microbial, 2001;39(4):1378-1384
9Tsuruoka M, Fujii T. Rapid and specific detection of RNA base sequence using fluorescence polorization. Nucl Acids Symp Ser, 1999;42:239-240
